.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report

Test Name Results Units Bio. Ref. Interval

SwasthFit Super 4

LIVER & KIDNEY PANEL, SERUM

(Reflectance Photometry,Idirect ISE)

Creatinine 0.90 mg/dL <1.20

GFR Estimated 99 mL/min/1.73m2 >59

GFR Category G1

Urea 23.50 mg/dL 18.00 - 55.00

Urea Nitrogen Blood 10.97 mg/dL 8.40 - 25.70

BUN/Creatinine Ratio 12

Uric Acid 5.60 mg/dL 3.4 - 7.0

AST (SGOT) 22.9 U/L <40

ALT (SGPT) 14.7 U/L <41

GGTP 27.4 U/L <71.00

Alkaline Phosphatase (ALP) 61.60 U/L <128

Bilirubin Total 0.55 mg/dL <1.10

Bilirubin Direct 0.27 mg/dL <0.20

Bilirubin Indirect 0.29 mg/dL <1.10

Total Protein 7.11 g/dL 6.40 - 8.30

Albumin 4.49 g/dL 3.50 - 5.20

A : G Ratio 1.71 0.90 - 2.00

Globulin(Calculated) 2.62 gm/dL 2.0 - 3.5

Calcium, Total 9.42 mg/dL 8.6 - 10.0

*458668632* Page 1 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report

Test Name Results Units Bio. Ref. Interval

Phosphorus 2.95 mg/dL 2.6 - 4.5

Sodium 138.60 mEq/L 136.00 - 145.00

Potassium 4.92 mEq/L 3.5 - 5.1

Chloride 100.50 mEq/L 98 - 108

Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.
2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1

LIPID SCREEN, SERUM

(CHOD-PAP)

Cholesterol, Total 253.00 mg/dL <200

Triglycerides 197.00 mg/dL <150.00

HDL Cholesterol 45.40 mg/dL >40

LDL Cholesterol, Calculated 168.20 mg/dL <100.00

VLDL Cholesterol,Calculated 39.40 mg/dL <30.00

Non-HDL Cholesterol 208 mg/dL <130

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400
mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400
mg/dL
3. Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for

*458668632* Page 2 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report

Test Name Results Units Bio. Ref. Interval

Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be
done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk
factors
4. Indians tend to have higher triglyceride levels & Lower HDL cholesterol combined with small dense
LDL particles, a pattern known as atherogenic dyslipidemia
5. Non HDL Cholesterol comprises the cholesterol carried by all atherogenic particles, including LDL, IDL,
VLDL & VLDL remnants, Chylomicron remnants & Lp(a)
6. LAI recommends LDL cholesterol as primary target and Non HDL cholesterol as co-primary treatment
target
7. Apolipoprotein B is an, secondary lipid target for treatment once LDL & Non HDL goals have been
achieved
8. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered among
patients with moderate risk for ASCVD for risk refinement

Treatment Goals as per Lipid Association of India 2020

--------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | <50 | <80 | | |
| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | | | | |
| Risk Group | ≤30 | ≤60 | >30 | >60 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Very | <50 | <80 | ≥50 | ≥80 |
| High | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------|--------------------|
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------|--------------------|--------------------|----------------|--------------------|
| Low | <100 | <130 | ≥130* | ≥160* |
--------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at
least 3 months

*458668632* Page 3 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report
Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT;CBC

(Electrical Impidence, Flow Cytometry, Sls.)

Hemoglobin 15.00 g/dL 13.00 - 17.00

Packed Cell Volume (PCV) 47.70 % 40.00 - 50.00

RBC Count 5.64 mill/mm3 4.50 - 5.50

MCV 84.60 fL 83.00 - 101.00

MCH 26.60 pg 27.00 - 32.00

MCHC 31.40 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 13.60 % 11.60 - 14.00

Total Leukocyte Count (TLC) 7.72 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Segmented Neutrophils 60.50 % 40.00 - 80.00
Lymphocytes 31.50 % 20.00 - 40.00
Monocytes 3.80 % 2.00 - 10.00
Eosinophils 3.80 % 1.00 - 6.00
Basophils 0.40 % <2.00
Absolute Leucocyte Count
Neutrophils 4.67 thou/mm3 2.00 - 7.00
Lymphocytes 2.43 thou/mm3 1.00 - 3.00
Monocytes 0.29 thou/mm3 0.20 - 1.00
Eosinophils 0.29 thou/mm3 0.02 - 0.50
Basophils 0.03 thou/mm3 0.02 - 0.10
Platelet Count 172 thou/mm3 150.00 - 410.00

Mean Platelet Volume 11.9 fL 6.5 - 12.0

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of

*458668632* Page 4 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report
Test Name Results Units Bio. Ref. Interval
blood
2. Test conducted on EDTA whole blood

*458668632* Page 5 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)

HbA1c 5.6 % 4.00 - 5.60

Estimated average glucose (eAG) 114 mg/dL

Interpretation
HbA1c result is suggestive of non diabetic adults (>=18 years)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines

------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------

*458668632* Page 6 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA 92.60 mg/dL 70.00 - 100.00

(Hexokinase)

VITAMIN B12; CYANOCOBALAMIN, SERUM 162.00 pg/mL 211.00 - 946.00

(ECLIA)
Notes
1. Interpretation of the result should be considered in relation to clinical circumstances.
2. It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or
plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical
suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is
more specific

3. False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking
antibodies, MMA measurement should be considered in such patients

4. The concentration of Vitamin B12 obtained with different assay methods cannot be used
interchangeably due to differences in assay methods and reagent specificity

VITAMIN D, 25 - HYDROXY, SERUM 34.40 nmol/L 75.00 - 250.00

(ECLIA)
Interpretation
-------------------------------------------------------------
| LEVEL | REFERENCE RANGE | COMMENTS |
| | IN nmol/L | |
|---------------|-----------------|---------------------------|
| Deficient | < 50 | High risk for developing |
| | | bone disease |
|---------------|-----------------|---------------------------|
| Insufficient | 50-74 | Vitamin D concentration |
| | | which normalizes |
| | | Parathyroid hormone |
| | | concentration |
|---------------|-----------------|---------------------------|
| Sufficient | 75-250 | Optimal concentration |
| | | for maximal health benefit|
|---------------|-----------------|---------------------------|
| Potential | >250 | High risk for toxic |
| intoxication | | effects |
-------------------------------------------------------------

Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.

*458668632* Page 7 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report

Test Name Results Units Bio. Ref. Interval

· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
· It shows seasonal variation, with values being 40-50% lower in winter than in summer.
· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available

Comments
Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency
in children causes Rickets and in adults leads to Osteomalacia. It can also lead to Hypocalcemia and
Tetany. Vitamin D status is best determined by measurement of 25 hydroxy vitamin D, as it is the major
circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs).

Decreased Levels
· Inadequate exposure to sunlight
· Dietary deficiency
· Vitamin D malabsorption
· Severe Hepatocellular disease
· Drugs like Anticonvulsants
· Nephrotic syndrome

Increased levels
Vitamin D intoxication

*458668632* Page 8 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report

Test Name Results Units Bio. Ref. Interval

THYROID PROFILE,TOTAL, SERUM

(ECLIA)
T3, Total 1.20 ng/mL 0.80 - 2.00

T4, Total 7.37 µg/dL 5.10 - 14.10

TSH 3.08 µIU/mL 0.27 - 4.20

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals

Dr. Jyoti Sharma Dr Nishant Bhagoliwal Dr.Vaibhav Tiwari

MBBS,MD Pathology DCP, Pathology MBBS MD (Pathology)
Consultant Pathologist Consultant Pathologist Consultant Pathologist
Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHJFIHNLGPEINJCBILLJCECCIJCIKPJNKEDFEFAPPAHEEEHA
BNFFFNBPAPBLAGIGFGECJGAPAOAHFHAKBKJOBCJGNLELNOJGMPBNFFFNB
GMDAFDFPNMOKEHONHFIAAJHFJGFEHEDDLKPHENFLMKLMOEFLBKHDEHANP
DJENEOFNBBHIELEIBINELEPFAFPLBLAFJIFFOAPAKKNJPDNLILNBKEMEL
LBJGJLFIOBFFDIADJKHGMHBLJENNKJAHKKMBAKMIPLKGKPNGKFFFOPKNG
CPCBBEFDOECAMIFKIEJOMIPBADHFOFAINDECBKDKBLIKOMNALNEJOGMKD
LNIMIJFFMLOBFOHIEOICOGFHIHAFJBAKOHGPBLMMKJCHKNFMIJNNMDILD
BNFNAMFMAKNPJIOMAANHDGIILKBMFMBPIFCCAMNNIJKDKPNGBNFMBHILL
NKJNCAFDDFHGFEILDOMIHFBKHENFEKFBJFFLBKOFOEBIOCNKDJPHNEKLJ
NPLLJGFCEPMJJDCJMMKOIDJDDDFKPNJHKEPHEDFLNKCKIGEOCIHKHMENL
HAIKNMFLGKKKNMAMPMAMAJEEINMFNNIBJNFEBFOFPNDMKPFKEPCIGCIMG
AGICGJFMMLDOFDNMHPCJPODEIEOPPFOEBOHPBLNOOLJAIANIPKONHDICL
MNNNNNEHKHAPJKAAGCFLHKNHJBAHFHADNKPFCMNLMKJIPFNNAHFHAHIKL
APBBBPAPBIMAEBFDFPAKCIIFAFFCHHCAONFFOKOGOLMHNLNFEDFCDBKHH
HHHHHHHPHHPPHPPHPHPPPHPPPHPPPPPPPPPHHPPPPHHHPHPHHHHPPHPHP

*458668632*
Page 9 of 10
.

Name : Mr. AKHILESH MISHRA

Lab No. : 458668632 Age : 59 Years
Ref By : SELF Gender : Male
Collected : 7/1/2024 9:46:00AM Reported : 7/1/2024 12:15:29PM
A/c Status : P Report Status : Final
Collected at : BHU LANKA Processed at : Dr. Lal Path Labs Ltd
Lanka ,Varanasi 221005

Test Report

Test Name Results Units Bio. Ref. Interval

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com

*458668632*
Page 10 of 10